Welcome to our dedicated page for Docusign SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Docusign, Inc. (NASDAQ: DOCU), a software company focused on digital agreements, eSignature, and Intelligent Agreement Management (IAM). Through these filings, investors can review the company’s official disclosures on financial performance, risk factors, governance, and key business developments.
Annual reports on Form 10-K typically include detailed discussions of DocuSign’s business, including its IAM platform, eSignature and contract lifecycle management offerings, customer base, and the risks and opportunities associated with its operations. Quarterly reports on Form 10-Q provide interim financial statements, management’s discussion and analysis, and updates on metrics such as revenue, subscription trends, billings, and cash flows.
Current reports on Form 8-K disclose material events, such as quarterly financial results and certain corporate governance changes. For example, DocuSign has used Form 8-K to report financial results for specific quarters and to announce board appointments and leadership roles. These filings help investors track significant developments between regular reporting periods.
Other filings, such as proxy statements and any Form 4 insider transaction reports, can offer additional insight into executive and director compensation, equity awards, and share ownership, as well as governance practices. Together, these documents form the regulatory record of DOCU as a Nasdaq-listed issuer.
On Stock Titan, SEC filings for DOCU are updated from the EDGAR system, and AI-powered summaries can assist readers by highlighting key points from lengthy documents like 10-Ks and 10-Qs. This can help users quickly understand DocuSign’s reported results, non-GAAP metrics, and material events without reading every page of each filing.
Docusign, Inc. reported that its Board of Directors appointed Brian Roberts to fill an existing vacancy on the Board, effective March 5, 2026. He will serve as a Class I director with a term running until the company’s 2028 Annual Meeting of Stockholders.
The Board determined that Brian Roberts qualifies as an independent director under securities laws and Nasdaq listing standards. The company states there is no arrangement with any other person regarding his selection and no material related-party transactions involving him. He will be compensated under Docusign’s existing director compensation program and has entered into the company’s standard indemnity agreement.
DOCUSIGN, INC. director Anna Marrs reported a mix of stock-based transactions. On March 5, 2026, she completed an open-market sale of 363 shares of common stock at
On March 4, 2026, she exercised 725 restricted stock units (RSUs), converting them into an equal number of common shares at
Anna Marrs submitted a Form 144 notice to sell restricted common stock. The filing lists 363 restricted shares to be sold through Morgan Stanley Smith Barney LLC with a sale date of 03/04/2026. The form also reports a prior sale of 365 common shares on 03/03/2026 with proceeds shown as 16432.30.
DOCUSIGN, INC. director Enrique T. Salem reported an automatic conversion of equity awards rather than an open-market trade. On February 28, 2026, he exercised 729 Restricted Stock Units (RSUs), which converted into 729 shares of common stock at a price of $0.00 per share. After this conversion, his directly held common stock position rose to 166,589 shares.
Each RSU represents the right to receive one share of common stock. The underlying RSU grant has a vest commencement date of May 29, 2025 and vests in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service. The RSUs themselves do not expire.
DocuSign director Teresa Briggs reported the conversion of restricted stock units into common shares. On the reported date, 729 Restricted Stock Units were exercised at a stated price of
DocuSign, Inc. director Irving Blake reported acquiring shares through an equity award. On February 28, 2026, 729 Restricted Stock Units were exercised or converted into 729 shares of common stock at a stated price of $0.00 per share, bringing his direct common stock holdings to 25,364 shares.
Each RSU represents a right to receive one share of common stock. The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, subject to continued service. The RSUs do not expire and will either vest or be canceled before the vesting date.
DocuSign director Peter Solvik reported an equity award transaction involving restricted stock units. On February 28, 2026, he exercised 729 Restricted Stock Units, which converted into 729 shares of DocuSign common stock at a stated price of $0.00 per share.
After this conversion, Solvik directly held 8,241 shares of common stock. The filing also notes indirect holdings as of that date, including 120,253 shares by a trust, 65,558 shares by children's trusts, 3 shares by a family partnership, and 6,458 shares by his spouse. Each RSU represents a right to receive one share and vests in quarterly installments over one year starting May 29, 2025.
DOCUSIGN, INC. director Mary Agnes Wilderotter acquired 729 shares of common stock through the exercise and conversion of Restricted Stock Units on February 28, 2026 at a price of $0.00 per share. Following this transaction, she directly holds 59,803 common shares.
Each RSU represents a right to receive one share of common stock. These RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to her continued service. The RSUs do not expire; they either vest or are canceled before vesting.
DocuSign director James A. Beer reported mixed insider activity. On March 3, 2026, he sold 450 shares of common stock in an open-market trade at $45.02 per share under a pre-arranged Rule 10b5-1 plan. On February 28, 2026, he acquired 729 shares of common stock from the conversion of 729 Restricted Stock Units. Following these transactions, he directly held 14,757 common shares, with an additional 5,543 shares held indirectly by a trust.
DOCUSIGN, INC. director Cain A. Hayes reported an equity award conversion rather than an open-market trade. On February 28, 2026, 729 Restricted Stock Units were exercised at $0.00 per unit, delivering 729 shares of common stock.
Following this transaction, Hayes directly owned 14,988 shares of DocuSign common stock. A separate line shows 729 Restricted Stock Units remaining directly held, each representing a contingent right to receive one share of common stock, subject to the disclosed vesting conditions.